neostigmine methylsulfate
Generic: neostigmine methylsulfate
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
neostigmine methylsulfate
Generic Name
neostigmine methylsulfate
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION
Routes
Active Ingredients
neostigmine methylsulfate 1 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1557
Product ID
51662-1557_10358f91-4225-7e42-e063-6394a90a62de
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209933
Listing Expiration
2026-12-31
Marketing Start
2021-06-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621557
Hyphenated Format
51662-1557
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
neostigmine methylsulfate (source: ndc)
Generic Name
neostigmine methylsulfate (source: ndc)
Application Number
ANDA209933 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/mL
Packaging
- 10 POUCH in 1 CASE (51662-1557-3) / 1 CARTON in 1 POUCH (51662-1557-2) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "10358f91-4225-7e42-e063-6394a90a62de", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["311936"], "spl_set_id": ["c4be8467-7b7e-551d-e053-2995a90a3045"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CASE (51662-1557-3) / 1 CARTON in 1 POUCH (51662-1557-2) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1557-3", "marketing_start_date": "20210614"}], "brand_name": "NEOSTIGMINE METHYLSULFATE", "product_id": "51662-1557_10358f91-4225-7e42-e063-6394a90a62de", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "51662-1557", "generic_name": "NEOSTIGMINE METHYLSULFATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEOSTIGMINE METHYLSULFATE", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA209933", "marketing_category": "ANDA", "marketing_start_date": "20210614", "listing_expiration_date": "20261231"}